Globe Newswire07.12.18
OrthoPediatrics Corp., a company exclusively focused on advancing the field of pediatric orthopedics, has launched the Pediatric Nailing Platform|FEMUR, OrthoPediatrics’ newest rigid intramedullary nailing system. The initial beta launch surgical cases utilizing this system, have received positive surgeon feedback and have reinforced OrthoPediatrics’ confidence in the full-scale U.S. launch of this offering.
The Pediatric Nailing Platform|FEMUR system features two distinct child and adolescent implant offerings optimized for pediatric-specific anatomy. The system also includes a full suite of new instrumentation. The system’s enhanced child nail offering ranges from 7mm to 9mm, while the new adolescent nails range from 9mm to 12mm. In combination with the novel carbon-fiber targeting arm, and other high precision instruments, the PNP|FEMUR system can effectively address both trauma and deformity correction procedures alike.
Greg Odle, executive vice president, stated, “The early feedback on PNP|FEMUR has been tremendous. This truly represents the first ever pediatric nailing platform the market has ever seen, and will be the foundation of our intramedullary technology going forward. It is the result of a very thoughtful and intentional development process, understanding the needs of the pediatric surgeons who treat femoral fractures and deformities. It’s another example of what OrthoPediatrics does; focusing ALL of our resources on helping children with orthopedic problems.”
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on providing a comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets 25 surgical systems that serve three of the largest categories within the pediatric orthopedic market. This offering spans trauma & deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and 38 countries outside the United States.
The Pediatric Nailing Platform|FEMUR system features two distinct child and adolescent implant offerings optimized for pediatric-specific anatomy. The system also includes a full suite of new instrumentation. The system’s enhanced child nail offering ranges from 7mm to 9mm, while the new adolescent nails range from 9mm to 12mm. In combination with the novel carbon-fiber targeting arm, and other high precision instruments, the PNP|FEMUR system can effectively address both trauma and deformity correction procedures alike.
Greg Odle, executive vice president, stated, “The early feedback on PNP|FEMUR has been tremendous. This truly represents the first ever pediatric nailing platform the market has ever seen, and will be the foundation of our intramedullary technology going forward. It is the result of a very thoughtful and intentional development process, understanding the needs of the pediatric surgeons who treat femoral fractures and deformities. It’s another example of what OrthoPediatrics does; focusing ALL of our resources on helping children with orthopedic problems.”
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on providing a comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets 25 surgical systems that serve three of the largest categories within the pediatric orthopedic market. This offering spans trauma & deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and 38 countries outside the United States.
